Florida Cancer Specialists, Sarasota Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2011
NCT01478178
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Alternative names

Florida Cancer Specialists, Sarasota, Florida 34232, USA

Active Ingredients

Drugs in Phase 2 Trials (1)

dianhydrogalactitol (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Brain Neoplasms (Phase 2)

Glioblastoma (Phase 2)

Glioma (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1